Another rare somatic mutation that has been reported in less than 1% of ET and PMF cases is MPL S505N, which is part of the TpoR transmembrane domain, and the mutation leads to constitutive dimerization of MPL/TpoR, leading to activation of the downstream signaling pathways [46,57,84]. This evidence concerns the gene MPL and essential thrombocythemia.